Surgical Treatment of Pancreatic Ductal Adenocarcinoma

被引:3
|
作者
Satoi, Sohei [1 ]
机构
[1] Kansai Med Univ, Dept Surg, Hirakata, Osaka 5731010, Japan
关键词
D O I
10.3390/cancers13164015
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页数:4
相关论文
共 50 条
  • [31] Long-term survival after curative resection for pancreatic ductal adenocarcinoma - Surgical treatment
    Benassai, G.
    Quarto, G.
    Perrotta, S.
    Furino, E.
    Benassai, G. L.
    Amato, B.
    Bianco, T.
    De Palma, G.
    Forestieri, P.
    INTERNATIONAL JOURNAL OF SURGERY, 2015, 21 : S1 - S3
  • [32] New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
    Ritu Raj Singh
    Eileen M. O’Reilly
    Drugs, 2020, 80 : 647 - 669
  • [33] Sustained Polyamine Depletion for the Treatment of Pancreatic Ductal Adenocarcinoma
    Dobrovolskaite, Aiste
    Altomare, Deborah
    Phanstiel, Otto
    FASEB JOURNAL, 2019, 33
  • [34] Proteogenomic insights into the biology and treatment of pancreatic ductal adenocarcinoma
    Yexin Tong
    Mingjun Sun
    Lingli Chen
    Yunzhi Wang
    Yan Li
    Lingling Li
    Xuan Zhang
    Yumeng Cai
    Jingbo Qie
    Yanrui Pang
    Ziyan Xu
    Jiangyan Zhao
    Xiaolei Zhang
    Yang Liu
    Sha Tian
    Zhaoyu Qin
    Jinwen Feng
    Fan Zhang
    Jiajun Zhu
    Yifan Xu
    Wenhui Lou
    Yuan Ji
    Jianyuan Zhao
    Fuchu He
    Yingyong Hou
    Chen Ding
    Journal of Hematology & Oncology, 15
  • [35] Characterization of a dualBET/HDACinhibitor for treatment of pancreatic ductal adenocarcinoma
    Zhang, Xin
    Zegar, Tim
    Weiser, Tim
    Hamdan, Feda H.
    Berger, Benedict-Tilman
    Lucas, Romain
    Balourdas, Dimitrios-IIias
    Ladigan, Swetlana
    Cheung, Phyllis F.
    Liffers, Sven-Thorsten
    Trajkovic-Arsic, Marija
    Scheffler, Bjoern
    Joerger, Andreas C.
    Hahn, Stephan A.
    Johnsen, Steven A.
    Knapp, Stefan
    Siveke, Jens T.
    INTERNATIONAL JOURNAL OF CANCER, 2020, 147 (10) : 2847 - 2861
  • [36] Neoadjuvant treatment for borderline and resectable pancreatic ductal adenocarcinoma
    Alvarez, R.
    Ales, I.
    Diaz, R.
    de Paredes, B. G.
    Hidalgo, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (10): : 1193 - 1198
  • [37] Everolimus for the treatment of advanced pancreatic ductal adenocarcinoma (PDAC)
    Babiker, Hani M.
    Karass, Michael
    Recio-Boiles, Alejandro
    Chandana, Sreenivasa R.
    McBride, Ali
    Mahadevan, Daruka
    EXPERT OPINION ON INVESTIGATIONAL DRUGS, 2019, 28 (07) : 583 - 592
  • [38] Evolving Paradigms in the Treatment of Oligometastatic Pancreatic Ductal Adenocarcinoma
    Chang, Enoch
    Sherry, Alexander D.
    Liermann, Jakob
    Abdollahi, Amir
    Tzeng, Ching-Wei D.
    Tang, Chad
    Aguilera, Todd A.
    Koay, Eugene J.
    Das, Prajnan
    Koong, Albert C.
    Pant, Shubham
    Ludmir, Ethan B.
    JOURNAL OF GASTROINTESTINAL CANCER, 2025, 56 (01)
  • [39] New Treatment Strategies for Metastatic Pancreatic Ductal Adenocarcinoma
    Singh, Ritu Raj
    O'Reilly, Eileen M.
    DRUGS, 2020, 80 (07) : 647 - 669
  • [40] Emerging kinase inhibitors for the treatment of pancreatic ductal adenocarcinoma
    Rudloff, Udo
    EXPERT OPINION ON EMERGING DRUGS, 2022, 27 (03) : 345 - 368